Skip to content

GRFS

Grifols SA

NASDAQ · Healthcare · Drug Manufacturers - General · ES

$7.31
−1.22%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
10.54x
P/E 2026E
7.67x
P/E 2027E
5.90x
P/E 2028E
4.50x
P/S forward
0.60x

Trailing multiples

Trailing twelve months

P/E TTM
9.51x
PEG TTM
0.42x
Price / book
0.78x
Price / sales
0.58x
Price / cash flow
3.96x

Enterprise value

Enterprise value
$16.9B
EV / sales
1.99x
EV / EBITDA
8.44x
EV / EBIT
11.92x
Market cap
$5.0B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026